The European Union and Central Asian countries have joined forces through the EU–Central Asia Action Plan on Drugs 2014–2020, building on earlier cooperation dating back to 2002. This plan recognises the shared challenges posed by drug...
The International Narcotics Control Board’s 2015 report on precursors highlights global efforts to stop chemicals being diverted into the illicit manufacture of drugs. It points to successes achieved through international cooperation...
In 2015, the UNODC-WCO Container Control Programme (CCP) expanded its reach with new Port Control Units (PCUs) across Asia and Europe, including in Bangladesh, Bosnia and Herzegovina, Georgia, Jordan, Nepal, Thailand and Viet Nam, as well...
Building the Future Together: Joanna Travis-Roberts on 10 Years of ISSUP
A special three-part series celebrating 10 years of the International Society of Substance Use Professionals (ISSUP).
In this first episode, host Associate...
Background
Opioid-related overdose is the leading cause of mortality among individuals recently released from incarceration in the U.S. Naloxone is an FDA-approved opioid antagonist medication designed to rapidly reverse opioid...
At the 66th Commission on Narcotic Drugs in March 2023, UNODC, together with international partners, hosted a side event on strengthening quality assurance in the treatment and recovery support of people with drug use disorders. Experts...
This EMCDDA paper introduces the European Union’s approach to drug supply reduction, explaining how policies, structures, and actions are designed to disrupt drug markets and limit the availability of illicit substances. It highlights the...
In June 2023, UNODC Serbia, with support from the Ministry of Health and international partners, hosted a training in Belgrade on quality assurance for drug use disorder treatment systems. Based on the UNODC-WHO International Standards and...
